ReCode Therapeutics to Participate in May Conferences

MENLO PARK, Calif.--(BUSINESS WIRE)--ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced that company management will participate in the upcoming May conferences: Wells Fargo Virtual Private Biotech Symposium Format: 1x1 Investor Meetings Date: May 6, 2024 Location: Virtual Capital One Biotech - Life Sciences Disruptors Event Format: Panel Discussion on “The Next Wave of m